Laxmi Dental Employee Stock Options
Laxmi Dental received NSE and BSE approvals for listing 7,911 ESOP equity shares. The shares will trade from September 18, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
27 announcements
Laxmi Dental received NSE and BSE approvals for listing 7,911 ESOP equity shares. The shares will trade from September 18, 2026.
Laxmi Dental Limited has announced its 22nd Annual General Meeting scheduled for September 25, 2026, and submitted its Annual Report for FY 2025-26.
Laxmi Dental Limited has scheduled its 22nd Annual General Meeting for September 25, 2026, via video conferencing. The agenda includes proposed variation of IPO proceeds utilization.
Laxmi Dental Limited has allotted equity shares under its ESOP/ESPS scheme. This corporate action updates the company's paid-up share capital.
Laxmi Dental Ltd approved the allotment of 7,911 equity shares under ESOP 2024. The board also proposed varying IPO objects and extending utilization timelines, pending shareholder approval.
Laxmi Dental reported record Q1 revenue driven by international expansion and scanner adoption, though higher operating costs and employee expenses tempered overall margin gains.
Laxmi Dental reported its highest-ever quarterly revenue of ₹74.7 Cr in Q1FY27, up 13.9% YoY. Strategy focuses on high-margin metal-free zirconia crowns and international expansion.
Laxmi Dental Limited reported the surrender and cancellation of 1,636 employee stock options (ESOPs). The company updated its share capital structure to reflect these changes.
Laxmi Dental reported Q1 FY27 revenue of ₹74.7 crore, up 13.9% year-on-year. Growth was driven by strong momentum in their dental laboratory and aligner solutions businesses.
Laxmi Dental Limited has filed the Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of its IPO proceeds.
Laxmi Dental Ltd reported revenue from operations of ₹74.7 Cr (+13.9% YoY) and net profit of ₹10.3 Cr (+24.1% YoY) for Q1 FY27.
Laxmi Dental Limited has scheduled a board meeting for August 11, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Laxmi Dental Ltd submitted its quarterly shareholding pattern disclosure for the period ending June 30, 2026, as required under SEBI regulations.
Laxmi Dental disbursed an unsecured loan of ₹0.25 Crore to its subsidiary Signature Smiles Dental Clinic. Outstanding loan balance now stands at ₹1.25 Crore.
Laxmi Dental reported its highest-ever quarterly revenue of ₹74cr (22% YoY) for Q4FY26, driven by record dental lab performance and international expansion.
Laxmi Dental Limited submitted its Annual Secretarial Compliance Report for FY2026. The report notes minor delays in financial filings and KMP resignation disclosures.
Laxmi Dental reported its highest quarterly revenue, recovering from a weak Q3 despite US tariff headwinds and domestic competition. Growth was driven by the dental lab segment and international expansion.
Laxmi Dental reported record quarterly revenue of ₹74 Cr in Q4FY26 with 21.9% YoY growth, driven by dental lab recovery and aligner solutions.
Laxmi Dental reported its highest-ever quarterly revenue for Q4FY26 at ₹74 Cr, driven by 27% growth in the Dental Laboratory business. The company maintains an integrated B2B2C model with high digital penetration.
Laxmi Dental reported its highest-ever quarterly revenue with 21.9% YoY growth in Q4FY26. Annual revenue reached ₹277.86 Crore, driven by strong Dental Laboratory and Aligner business growth.
Laxmi Dental Ltd reported revenue from operations of ₹74 Cr (+21.9% YoY) and net profit of ₹10.1 Cr (+134.9% YoY) for Q4 FY26.
Laxmi Dental Limited reported FY26 standalone total income of ₹216.58 Crore and net profit of ₹19.34 Crore. The Board approved audited results with an unmodified opinion.
Laxmi Dental Limited scheduled a board meeting for May 21, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Laxmi Dental Limited submitted its Monitoring Agency Report for the March 2026 quarter regarding ₹138.00 Crore IPO proceeds. ICRA reported no material deviations in fund utilization.
Laxmi Dental Limited received in-principle approval from BSE for listing 5,00,000 equity shares of Rs. 2/- each. These shares are to be issued under the Laxmi Dental Employee Stock Option Scheme 2024, following the exercise of options by employees.
Laxmi Dental Limited received in-principle approval from NSE for listing 5,00,000 equity shares under its Employee Stock Option Scheme 2024. The approval follows the company's application for shares with a face value of Rs. 2/- each. This administrative milestone facilitates the eventual allotment and trading of shares for employees.
Laxmi Dental Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ending March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and substituted in the register of members within prescribed timelines.